Skip to main content
Article
NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933
Neuro-oncology (2017)
  • Joseph Bovi, Medical College of Wisconsin
  • Stephanie L Pugh, NRG Energy
  • David Sabsevitz, Medical College of Wisconsin
  • Clifford G Robinson, Washington University in St. Louis
  • Eric Paulson, Medical College of Wisconsin
  • Minesh P Mehta, University of Maryland, Baltimore
  • Vinai Gondi, University of Wisconsin-Madison
  • Vijayananda Kundapur, University of Saskatchewan
  • Wayne H Pinover, Memorial Hospital of South Bend
  • Samuel T Chao, Cleveland Clinic
  • Mitch Machtay
  • Albert S DeNittis, University of Pennsylvania
  • Nadia N Laack, Mayo Clinic
  • Jeffrey N Greenspoon, McMaster University
  • Robert S Mannel
  • Jiayi Huang, Washington University in St. Louis
  • Michael M Dominello
  • Lisa A Kachnic, Vanderbilt University Medical Center
Publication Date
November 6, 2017
DOI
10.1093/neuonc/nox168.563
Citation Information
Joseph Bovi, Stephanie L Pugh, David Sabsevitz, Clifford G Robinson, et al.. "NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933" Neuro-oncology Vol. 19 (2017)
Available at: http://works.bepress.com/minesh-mehta/9/